Since the Cleveland Innovation District launched in 2021, the founding institutions have made significant progress, including exceeding many of the targets set
Cleveland Clinic has opened the first phase of its 341,000-square-foot innovation district, a public-private initiative with the state of Ohio and JobsOhio.
Cleveland Clinic researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that currently has no prevention, treatment or cure.
Cleveland Clinic researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that currently has no prevention, treatment or cure.
The patent-pending vaccine uses nanoparticles to carry the antigens that contain instructions for fighting off a virus. Nanoparticle vaccines are designed to effectively deliver antigens at a lower dose with fewer side effects for at-risk groups – including adults over age 50, who are the most vulnerable to SFTSV and the most susceptible to vaccine side effects.
Promising Nanoparticle Vaccine Battles Emerging Tick-Borne Virus miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.